Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

INOZYME PHARMA

Filed by THE KPM GROUP DC LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 17, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
7f4f7ec9-3acc-4ae2-9490-c3f7c30fe625
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

H.R.1262/S.932 - Give Kids a Chance Act H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532/S.822 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act

Literal federal measure citations: H.R.1262, S.932, H.R.946, H.R. 1414, H.R.1532, S.822, H.R.1492

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.